XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Operations (unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]        
Product revenue $ 36,584 $ 18,240 $ 70,332 $ 89,714
Cost of product revenue 72,807 39,363 119,651 148,494
Product gross profit (loss) (36,223) (21,123) (49,319) (58,780)
Collaborations revenue 20,113 6,374 42,387
Operating expenses:        
Selling, general and administrative 1,818,207 1,313,252 3,560,348 2,507,112
Research and development 1,205,380 1,081,429 2,265,842 2,015,587
Total operating expenses 3,023,587 2,394,681 5,826,190 4,522,699
Loss from operations (3,059,810) (2,395,691) (5,869,135) (4,539,092)
Interest expense (3,053)
Net valuation change of instruments measured at fair value 1,974
Other income 1,743 1,775 3,593 186,775
Loss before income taxes (3,058,067) (2,393,916) (5,865,542) (4,353,396)
Provision for income taxes
Net loss $ (3,058,067) $ (2,393,916) $ (5,865,542) $ (4,353,396)
Net loss per share:        
Basic and diluted (in Dollars per share) $ (0.19) $ (0.21) $ (0.37) $ (0.46)
Number of shares used in per share calculations:        
Basic and diluted (in Shares) 16,189,867 11,238,084 15,794,880 9,419,599